AI-driven drug discovery and diagnostics development using multimodal patient data.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: December 2025
This analysis is not yet available in English. Please see the French version.
Leading organizations
Numa Health
B
Development of predictive health solutions based on multi-source data collection and analysis to optimize medical decision-making and patient care.
Magentine Healthcare
B
Providing connected services and products to enhance medical services in medical biology. Using generative AI to assist patients in understanding their analysis results.
OrionPharma
B
Development and production of pharmaceuticals, with a focus on research and development using artificial intelligence for new drug discovery.
Initiatives identified among leaders
Utilisation d'électricité verte pour les processus de fabrication
“Orion Pharma utilise de l'électricité verte pour s...” - OrionPharmaRéduction du coût des soins
“Magentine healthcare participe à la réduction du c...” - Magentine HealthcareSolutions innovantes pour la santé
“Magentine healthcare développe des solutions innov...” - Magentine Healthcare32% of similar organizations communicate on CSR issues
+1085 initiatives collected from 100 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports